Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2016 Filed Jan 4, 2017 17:31 UTC |
LIDDY EDWARD MDirector
|
GrantStock Equivalent Units · Derivative | 499 | $62.62 Strike: $0.00 | $31,247.38 |
DisclosureSEC source: 0001179110-17-000297 · edgar.xml · derivative · entry 1 LIDDY EDWARD M · CIK 0001188983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,423 Underlying: Common stock · 499 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 22:32 UTC |
RAPP EDWARD JDirector
|
GrantStock Equivalent Units · Derivative | 523 | $62.62 Strike: $0.00 | $32,750.26 |
DisclosureSEC source: 0001179110-17-000300 · edgar.xml · derivative · entry 1 RAPP EDWARD J · CIK 0001171780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,331 Underlying: Common Stock · 523 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 17:33 UTC |
TILTON GLENN FDirector
|
GrantStock Equivalent Units · Derivative | 598 | $62.62 Strike: $0.00 | $37,446.76 |
DisclosureSEC source: 0001179110-17-000303 · edgar.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,342 Underlying: Common Stock · 598 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 09, 2016 Filed Dec 9, 2016 22:08 UTC |
Gosebruch Henry OChief Strategy Officer
|
Tax withholdingCommon stock, $0.01 par value | 13,871 | $60.90 | $844,743.90 |
DisclosureSEC source: 0001179110-16-032747 · edgar.xml · nonDerivative · entry 1 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,179 Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 17:08 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
GiftCommon Stock, $0.01 par value | 3,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-032746 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,581 Read SEC document |
| December 02, 2016 Filed Dec 2, 2016 22:08 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
Exercise / conversionOption (right to buy) · Derivative | 6,600 | $0.00 Strike: $27.29 | $0.00 |
DisclosureSEC source: 0001179110-16-032340 · edgar.xml · derivative · entry 4 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 6,600 shares Expires 2017-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2016 Filed Dec 2, 2016 22:08 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
SaleCommon stock, $0.01 par value | 6,600 | $59.19 | $390,654.00 |
DisclosureSEC source: 0001179110-16-032340 · edgar.xml · nonDerivative · entry 2 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,370 Read SEC document |
| December 02, 2016 Filed Dec 2, 2016 22:08 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
Exercise / conversionCommon stock, $0.01 par value | 6,600 | $27.29 | $180,114.00 |
DisclosureSEC source: 0001179110-16-032340 · edgar.xml · nonDerivative · entry 1 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,970 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2016 Filed Dec 2, 2016 22:08 UTC |
Schumacher Laura JExecutive Vice President
|
GiftCommon stock, $0.01 par value | 2,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-032341 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,159 Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 22:39 UTC |
HURWICH THOMAS A.VP, Controller
|
GrantOption (right to buy) · Derivative | 3,100 | $0.00 Strike: $28.86 | $0.00 |
DisclosureSEC source: 0001179110-16-031870 · edgar.xml · derivative · entry 5 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,100 Underlying: Common stock · 3,100 shares Expires 2018-02-14 Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 22:39 UTC |
HURWICH THOMAS A.VP, Controller
|
SaleCommon stock, $0.01 par value | 3,100 | $62.00 | $192,200.00 |
DisclosureSEC source: 0001179110-16-031870 · edgar.xml · nonDerivative · entry 2 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,449 Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 22:39 UTC |
HURWICH THOMAS A.VP, Controller
|
Exercise / conversionCommon stock, $0.01 par value | 3,100 | $28.86 | $89,474.68 |
DisclosureSEC source: 0001179110-16-031870 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 21:44 UTC |
Alpern Robert JDirector
|
GrantStock Equivalent Units · Derivative | 104 | $63.07 Strike: $0.00 | $6,559.28 |
DisclosureSEC source: 0001179110-16-030339 · edgar.xml · derivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,044 Underlying: Common Stock · 104 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 17:45 UTC |
LIDDY EDWARD MDirector
|
GrantStock Equivalent Units · Derivative | 495 | $63.07 Strike: $0.00 | $31,219.65 |
DisclosureSEC source: 0001179110-16-030340 · edgar.xml · derivative · entry 1 LIDDY EDWARD M · CIK 0001188983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,772 Underlying: Common stock · 495 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 21:46 UTC |
RAPP EDWARD JDirector
|
GrantStock Equivalent Units · Derivative | 519 | $63.07 Strike: $0.00 | $32,733.33 |
DisclosureSEC source: 0001179110-16-030341 · edgar.xml · derivative · entry 1 RAPP EDWARD J · CIK 0001171780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,720 Underlying: Common Stock · 519 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 17:51 UTC |
TILTON GLENN FDirector
|
GrantStock Equivalent Units · Derivative | 594 | $63.07 Strike: $0.00 | $37,463.58 |
DisclosureSEC source: 0001179110-16-030342 · edgar.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,512 Underlying: Common Stock · 594 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 07, 2016 Filed Sep 9, 2016 21:38 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 50,000 | $65.00 | $3,250,000.00 |
DisclosureSEC source: 0001179110-16-029507 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,138 Read SEC document |
| August 05, 2016 Filed Aug 8, 2016 21:43 UTC |
HURWICH THOMAS A.VP, Controller
|
GiftCommon stock, $0.01 par value | 755 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-028396 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,449 Read SEC document |
| June 30, 2016 Filed Jul 15, 2016 23:47 UTC |
Alpern Robert JDirector
|
GrantStock Equivalent Units · Derivative | 120 | $61.91 Strike: $0.00 | $7,429.20 |
DisclosureSEC source: 0001179110-16-027683 · edgar.xml · derivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,898 Underlying: Common Stock · 120 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2016 Filed Jul 15, 2016 19:49 UTC |
LIDDY EDWARD MDirector
|
GrantStock Equivalent Units · Derivative | 539 | $61.91 Strike: $0.00 | $33,369.49 |
DisclosureSEC source: 0001179110-16-027684 · edgar.xml · derivative · entry 1 LIDDY EDWARD M · CIK 0001188983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,140 Underlying: Common stock · 539 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature. Read SEC document |
| June 30, 2016 Filed Jul 15, 2016 23:52 UTC |
RAPP EDWARD JDirector
|
GrantStock Equivalent Units · Derivative | 531 | $61.91 Strike: $0.00 | $32,874.21 |
DisclosureSEC source: 0001179110-16-027685 · edgar.xml · derivative · entry 1 RAPP EDWARD J · CIK 0001171780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,124 Underlying: Common Stock · 531 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2016 Filed Jul 15, 2016 19:54 UTC |
TILTON GLENN FDirector
|
GrantStock Equivalent Units · Derivative | 573 | $61.91 Strike: $0.00 | $35,474.43 |
DisclosureSEC source: 0001179110-16-027686 · edgar.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,709 Underlying: Common Stock · 573 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 38,333 | $0.00 Strike: $24.21 | $0.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · derivative · entry 26 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 38,333 shares Expires 2021-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 42,533 | $0.00 Strike: $28.31 | $0.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · derivative · entry 25 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 42,533 shares Expires 2020-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 38,940 | $0.00 Strike: $28.13 | $0.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · derivative · entry 24 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 38,940 shares Expires 2019-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 66,300 | $0.00 Strike: $28.86 | $0.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · derivative · entry 23 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 66,300 shares Expires 2018-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 300 | $60.15 | $18,043.50 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 22 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,138 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 200 | $60.14 | $12,028.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 21 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,438 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 100 | $60.13 | $6,012.50 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 20 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,638 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 100 | $60.12 | $6,012.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 19 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,738 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 100 | $60.11 | $6,011.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 18 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,838 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 100 | $60.09 | $6,009.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 17 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,938 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 200 | $60.08 | $12,016.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 16 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,038 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 100 | $60.07 | $6,007.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 15 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,238 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 100 | $60.07 | $6,006.50 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 14 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,338 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 100 | $60.06 | $6,006.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 13 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,438 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 72,500 | $60.05 | $4,353,625.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 12 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,538 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 25,000 | $60.04 | $1,501,000.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 11 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,038 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 300 | $60.03 | $18,009.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 10 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,038 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 100 | $60.03 | $6,002.50 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 9 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,338 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 300 | $60.02 | $18,006.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 8 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,438 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 1,100 | $60.01 | $66,011.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 7 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,738 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 1,513 | $60.01 | $90,787.57 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 6 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,838 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 83,893 | $60.00 | $5,033,580.00 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 5 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,351 Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon stock, $0.01 par value | 38,333 | $24.21 | $927,972.93 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 4 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon stock, $0.01 par value | 42,533 | $28.31 | $1,204,202.80 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon stock, $0.01 par value | 38,940 | $28.13 | $1,095,191.39 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,378 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2016 Filed Jun 28, 2016 21:47 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon stock, $0.01 par value | 66,300 | $28.86 | $1,913,603.64 |
DisclosureSEC source: 0001179110-16-027030 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,438 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
Exercise / conversionOption(right to buy) · Derivative | 285,953 | $0.00 Strike: $35.88 | $0.00 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · derivative · entry 30 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 285,953 shares Expires 2023-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2016 Filed Jun 3, 2016 17:26 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
SaleCommon stock, $0.01 par value | 1,700 | $63.92 | $108,655.50 |
DisclosureSEC source: 0001179110-16-025997 · edgar.xml · nonDerivative · entry 27 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,421 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.